Dr. Martens PLC Ordinary Shares (DOCS)

Industry Footwear & Accessories


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

78.05p

Buy

78.50p

arrow-down-0.10p (-0.13%)

Prices updated at 16 Dec 2025, 16:05 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Sector
Consumer Cyclical
Industry
Footwear & Accessories
Chairman
Mr. Paul Mason
CEO
Mr. Ije Nwokorie
Most recent earnings
31 Mar 2025
Fiscal year end
31 Mar 2025
Employees
3,700
Head office
28 Jamestown Road
London
United Kingdom
NW1 7BY
mobile
+44 2039086901
letter
company.secretariat@drmartens.com

Key personnel

Salary
Ms. Lynne Marie Weedall
Non-Executive Director, Senior Independent Non-Executive Director
-
Mr. Paul Mason
Non-Executive Director, Chairman
-
Mr. Andrew John Harrison
Non-Executive Director
-
Mr. Robert Lee Hanson
Non-Executive Director
-
Ms. Robyn Perriss
Non-Executive Director
-
Mr. Ian Rogers
Non-Executive Director
-
Mr. Giles Wilson
Executive Director, Chief Financial Officer
-
Mr. Ije Nwokorie
Executive Director, Chief Executive Officer
-

Top 5 shareholders

No. of shares
Artemis Investment Management LLP68,979,480
UWS Artemis Income B55,410,311
Franklin Templeton Investments35,467,773
Fidelity Management & Research Company LLC33,014,769
Franklin Small Cap Value Fund28,142,109

Director dealings

Action
11 Dec 2025Purchase
11 Dec 2025Transfer in
11 Dec 2025Purchase
11 Dec 2025Transfer in
11 Dec 2025Purchase
05 Dec 2025Purchase
11 Nov 2025Transfer in
11 Nov 2025Purchase
11 Nov 2025Purchase
11 Nov 2025Transfer in
15 Oct 2025Sale
15 Oct 2025Transfer in
13 Oct 2025Transfer in
13 Oct 2025Purchase
13 Oct 2025Purchase
13 Oct 2025Transfer in
08 Oct 2025Purchase
08 Oct 2025Purchase
11 Sep 2025Transfer in
11 Sep 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.